Introduction
CYP2B6 is involved in the metabolism of clinically important drugs; including cyclophosphamide, 1) ifosfamide, 2) bupropion, 3, 4) tamoxifen, 5) and diazepam. 6) The capacity of the activation has been reported to vary among individuals from four to nine times. Recent publications indicate that the extensive interindividual variability of CYP2B6 expression and function is due not only to regulatory phenomena, but also to a common genetic polymorphism. 7) In addition to the wild-type allele CYP2B6*1, to date there are eight variants, designated CYP2B6*2 (64CÀT), CYP2B6*3 (777CÀA), CYP2B6 * 4 (785AÀG), CYP2B6 * 5 (1459CÀT), CYP2B6 * 6 (516GÀT and 785AÀG), CYP2B6 * 7 (516GÀT, 785AÀG and 1459CÀT), CYP2B6 * 8 (415AÀG), and CYP2B6 * 9 (516GÀT) (see http: W W www.imm.ki.se W CYPalleles W ). 7, 8) Recently, we have reported allele frequencies for CYP2B6*2-7 in 256 Japanese subjects using genotyping methods. 9) In this study, we sequenced all exons and exon-intron junctions of the CYP2B6 gene from 200 Japanese individuals. We identiˆed three novel SNPs of the CYP2B6 gene.
Materials and Methods
Venous blood was obtained from 200 unrelated Japanese volunteers of Tohoku University Hospital. The local Ethics Committee of Tohoku University Hospital and Tohoku Pharmaceutical University approved the study and written, informed consent was obtained from all blood donors. DNA was isolated from anticoagulated (with K2EDTA) peripheral blood using a DNA Extractor WB-Rapid Kit (Wako Pure Chemical Industries, Osaka, Japan) or a QIAamp DNA Mini Kit (QIAGEN, Hilden, Germany) according to the manufacturer's recommendations. Table 1 lists the primer pairs (PCR) used to amplify CYP2B6 exons. These primers were designed based on the genomic sequence reported in the Genbank with accession number: AC023172. Amplicons for exons 1, 4, 7-8, and 9 were generated with the AmpliTaq Gold PCR Master Mix by Applied Biosystems (Foster City, CA, USA). The PCR reactions proceeded using a BIO-RAD iCycler (Hercules, CA, USA). The thermal proˆle consisted of denaturation at 959 C for 10 minutes, followed by 30 cycles of denaturation at 959 C for 30 seconds, annealing for 30 seconds, extension at 729 C for 30 seconds, and aˆnal extension at 729 C for 7 minutes. The annealing temperatures are indicated in Table 1 . Amplicons for exons 2-3 were generated with the LA-Taq DNA polymerase by TaKaRa Co. (Kyoto, Japan). The thermal proˆle consisted of denaturation at 949 C for 5 minutes, followed by 30 cycles of denaturation at 949 C for 30 seconds, annealing at 659 C for 60 seconds, extension at 729 C for 90 seconds, and aˆnal extension at 729 C for 7 minutes. Amplicons for exons 5-6 were generated with the Ex-Taq DNA polymerase by TaKaRa Co. (Kyoto, Japan). The thermal proˆle consisted of denaturation at 949 C for 5 minutes, followed by 30 cycles of denaturation at 949 C for 30 seconds, annealing at 64.39 C for 60 seconds, extension at 729 C for 90 seconds, and aˆnal extension at 729 C for 7 minutes.
Sequences were determined using the CEQ8000 } automated DNA sequencer (Beckman-Coulter Inc., Fullerton, CA, USA). The PCR products were sequenced by the ‰uorescent dideoxy termination reaction method using the DTCS DNA Sequencing Kit (Beckman-Coulter Inc.) according to manufacturer's instructions with the primers (sequence) listed in Table 1 .
Results and Discussion
We found three novel SNPs as follows: 1) SNP, 031226Hiratsuka01; GENE NAME, CYP2B6 ; ACCESSION NUMBER, AC023172; LENGTH, 25 base; 5?-CAGAACTTCTCCA W GTGGC-CAGCCCCG-3?. 2) SNP, 031226Hiratsuka02; GENE NAME, CYP2B6 ; ACCESSION NUMBER, AC023172; LENGTH, 25 base; 5?-CCCAGGAGTGTGG W ATGT-GGGCAAAAT-3?. 3) SNP, 031226Hiratsuka03; GENE NAME, CYP2B6 ; ACCESSION NUMBER, AC023172; LENGTH, 25 base; 5?-CCCCAACATACCA W TGAT-CCGCTTCCT-3?.
The electropherograms of the novel SNPs are shown in Fig. 1 . The positions of these SNPs were 459 (031226Hiratsuka01), 476 (031226Hiratsuka02), and 485 (031226Hiratsuka03) in exon 9. All of the SNPs were heterozygous, and their frequencies were 0.0075 for 031226Hiratsuka01, 0.005 for 031226Hiratsuka02, and 0.0025 for 031226Hiratsuka03 in the Japanese population. Sequences from each sample were obtained from at least three diŠerent PCR ampliˆcations.
Ariyoshi Novel SNPs of CYP2B6 in Japanese SNP3 (157) signiˆcantly reduced CYP2B6 protein expression and S-mephenytoin N-demethylase activity were found in carriers of the 1459CÀT (Arg 487 Cys) mutation (alleles CYP2B6 * 5 and CYP2B6 * 7).
7) Furthermore, it has been reported that the 1459CÀT (Arg 487 Cys) are associated with the lowest level of CYP2B6 activity in livers of females.
8) The 1459CÀT SNP in exon 9 are closely located in the substrate recognition site. 13) These three SNPs in this study are also located in the site. In particular, the Gly476 is conserved in the CYP2 family. 13) Thus, these amino acid substitutions are expected to alter the catalytic properties of the CYP2B6.
